ZLAB (Zai Lab) 6-Month Price Index: 1.07 (As of Jul. 09, 2026)


ZLAB Zai Lab Ltd ZLAB
64 GF Score
Price $19.98
GF Value $30.24
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Zai Lab 6-Month Price Index?

Zai Lab ZLAB +1.22% 64 6-Month Price Index is 1.07 as of Jul. 09, 2026. GuruFocus rates ZLAB with a GF Score™ of 64/100 and a GF Value™ of $30.24 (Possible Value Trap). The stock has 7 warning signs investors should review.

6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. It’s calculated by current share price divided by share price 6-months ago. As of today (2026-07-09), Zai Lab's 6-Month Price Index is 1.07.

Zai Lab  (NAS:ZLAB) 6-Month Price Index Explanation

Price Index (PI) also called momentum. Strategies involving Price Index are also known as momentum strategies as they allow investors to profit from a company’s stock price. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago.

The investment strategy for momentum investors is to buy winners and sell losers. That is, buy stocks that performed well and sell stocks that performed poorly in the past.

Zai Lab 6-Month Price Index Related Terms

ZLAB vs STOK, ADMA, VRDN: 6-Month Price Index Comparison

For the Biotechnology subindustry, Zai Lab's 6-Month Price Index, along with its competitors' market caps and 6-Month Price Index data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ZLAB
64GF Score
Zai Lab Ltd ZLAB
6-Month Price Index is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zai Lab  (NAS:ZLAB) 6-Month Price Index Calculation

6-Month Price Index is calculated as following:

6-Month Price Index=Current Share Price / Share Price 6-Months Ago

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 6-Month Price Index →
What does a 6-Month Price Index of 1.07 mean?
Zai Lab (ZLAB) has a 6-Month Price Index of 1.07 as of Jul. 09, 2026. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Zai Lab and its competitors.
Is Zai Lab's 6-Month Price Index too high?
Zai Lab's current 6-Month Price Index is 1.07. Overall, Zai Lab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Zai Lab's 6-Month Price Index compare to STOK and ADMA?
Zai Lab's 6-Month Price Index of 1.07 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 6-Month Price Index for a Biotechnology company?
A good 6-Month Price Index depends on the Biotechnology industry context. However, 6-Month Price Index should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 6-Month Price Index mean?
A high 6-Month Price Index can signal that a stock is expensive relative to its fundamentals. 6-Month Price Index is an intermediate-term momentum that shows the price change relative to 6-month ago. View historical data on Zai Lab and its competitors. Zai Lab's current 6-Month Price Index is 1.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zai Lab stock overvalued right now?
Based on GuruFocus' analysis, Zai Lab (ZLAB) is currently considered Possible Value Trap. The stock's GF Value™ is $30.24, compared to a current price of $19.98 — trading 33.9% below its estimated fair value. The current 6-Month Price Index is 1.07. Zai Lab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 6-Month Price Index calculated?
6-Month Price Index is calculated from a company's financial statements. For Zai Lab (ZLAB), the current 6-Month Price Index is 1.07 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zai Lab (ZLAB) Overvalued in 2026?

Based on GuruFocus' analysis, Zai Lab stock appears to be undervalued. The current stock price of $19.98 is trading 33.9% below its estimated GF Value™ of $30.24. GuruFocus considers Zai Lab to be Possible Value Trap.

Key valuation signals for ZLAB:

  • 6-Month Price Index: 1.07
  • GF Value™: $30.24 vs. price of $19.98 (33.9% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the ZLAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zai Lab Business Description

Other Exchanges 09688:Hong Kong1ZLB:Germany
Address 899 Halei Road, Building B, Pudong, Shanghai, CHN, 201203
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.
64GF Score

Get the complete analysis for ZLAB

6-Month Price Index is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.98
Price
$30.24
GF Value